ChemicalBook >> CAS DataBase List >>TAK-041

TAK-041

CAS No.
1929519-13-0
Chemical Name:
TAK-041
Synonyms
TAK-041;NBI-1065846;TAK-041 (Synonyms: NBI-1065846);1,2,3-Benzotriazine-3(4H)-acetamide, 4-oxo-N-[(1S)-1-[4-(trifluoromethoxy)phenyl]ethyl]-;(S)-2-(4-Oxobenzo[d][1,2,3]triazin-3(4H)-yl)-N-(1-(4-(trifluoromethoxy)phenyl)ethyl)acetamide;inhibit,deficits,social,BALB/c,NBI 1065846,NBI1065846,negative,schizophrenia,TAK-041,GPR139,symptoms,interaction,G Protein-Coupled Receptor 139,TAK 041,mouse,TAK041,Inhibitor
CBNumber:
CB74694907
Molecular Formula:
C18H15F3N4O3
Molecular Weight:
392.33
MDL Number:
MFCD32858822
MOL File:
1929519-13-0.mol
Last updated:2023-09-20 16:43:00

TAK-041 Properties

Density 1.42±0.1 g/cm3(Predicted)
solubility DMF: 3 mg/ml; DMSO: 1 mg/ml; Ethanol: insol; PBS (pH 7.2): insol
form A crystalline solid
pka 13.89±0.46(Predicted)

TAK-041 Preparation Products And Raw materials

Raw materials

Preparation Products

TAK-041 Suppliers

Global( 18)Suppliers
Supplier Tel Email Country ProdList Advantage
TargetMol Chemicals Inc.
+1-781-999-5354 support@targetmol.com United States 19973 58
Nanjing Chemlin Chemical Co., Ltd 025-83697070 info@chemlin.com.cn China 18086 64
ShangHai Caerulum Pharma Discovery Co., Ltd. 18149758185 sales-cpd@caerulumpharma.com China 3427 58
ShangHai Biochempartner Co.,Ltd 17754423994 17754423994 2853530910@QQ.com China 8013 62
Shanghai Chaolan Chemical Technology Center QQ:65489617 15618227136 info@SuperLan-chem.com China 9838 58
Shanghai Tube Pharmaceutical Co., Ltd. 021-54338626 18017892860 sales@tubepharm.com China 2329 58
DC Chemicals 021-58447131 13564518121 sales@dcchemicals.com China 9412 58
Suzhou youruike Chemical Pharmaceutical Technology Co., Ltd 15317229551 15151849396@163.com China 997 58
Chunchuang (Wuhan) Technology Co., Ltd 15342225168 yutianchun2007@126.com China 10006 58
Bide Pharmatech Ltd. 400-1647117 15221909166 product02@bidepharm.com China 63720 58

TAK-041 Spectrum

TAK-041 NBI-1065846 TAK-041 (Synonyms: NBI-1065846) (S)-2-(4-Oxobenzo[d][1,2,3]triazin-3(4H)-yl)-N-(1-(4-(trifluoromethoxy)phenyl)ethyl)acetamide inhibit,deficits,social,BALB/c,NBI 1065846,NBI1065846,negative,schizophrenia,TAK-041,GPR139,symptoms,interaction,G Protein-Coupled Receptor 139,TAK 041,mouse,TAK041,Inhibitor 1,2,3-Benzotriazine-3(4H)-acetamide, 4-oxo-N-[(1S)-1-[4-(trifluoromethoxy)phenyl]ethyl]- 1929519-13-0